MEDS stock news · DataMEDS AI, Inc.
Get alerts for MEDS
Follow DataMEDS AI, Inc. (MEDS) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for MEDSDatavault AI plans to buy a 19.9% share in DataMEDS AI to improve its healthcare technology.
NeutralThe proposed technology could add patient-data and medication tools to DataMEDS's platform, but DataMEDS would pay the costs of bringing them to market. Because the deal is nonbinding and no business results are reported, this does not yet change its outlook.
12 health care stocks are changing a lot before the market opens on Monday.
NeutralDataMEDS AI shares rose about 20% before trading began. The story gives no reason or company news, so it does not change the company's business outlook.
DataMeds AI, Inc. has signed an important agreement with REBOOT Health AI, Inc.
NeutralDataMeds secured a limited U.S. platform license for its consumer GLP-1 business, but share costs, revenue sharing, and pending Nasdaq confirmation leave its outlook unsettled.
12 health care companies are changing prices before the market opens on Monday.
NeutralDataMEDS AI shares rose about 15% before Monday's open, but the article gives no business reason, so its outlook is unchanged.
On Thursday, 12 health care stocks saw big price changes, with Nexalin Technology jumping up 77.8%.
NeutralDataMEDS AI shares rose 18.61% during Thursday's session, but the article gives no company news explaining the move, so its business outlook is unchanged.
12 health care stocks are changing a lot before the market opens on Thursday.
NeutralMEDS AI shares rose 39.4% in pre-market trading. The article gives no business news to explain the move or change the company's outlook.
Here are 12 health care stocks that changed a lot during Monday's trading.
NeutralDataMEDS AI shares rose about 39%, but the article gives no company news explaining the move. It does not change DataMEDS AI's business outlook.
12 health care stocks are changing a lot before the market opens on Monday.
NeutralThe report says DataMEDS AI shares rose 29.58% to $4.03 before trading. It gives no company news explaining the move, so the story does not change the company's outlook.
On Friday evening, 12 health care stocks saw big changes in their prices.
NeutralMEDS jumped in after-hours trading, but the article contains only price data and no company news, so the company's reading stays unchanged.
On Friday, 12 health care stocks changed a lot in price, with IM Cannabis jumping 246%.
Bad for MEDSDataMEDS AI shares decreased 17.08% to $3.85. The drop indicates negative investor sentiment and lowers the company's market value today.
On Thursday, 12 health care stocks changed a lot, with Aethlon Medical jumping 330.8% and Longeveron dropping 57.3%.
NeutralDataMEDS AI slid in the session, but the writeup only lists the price change and market cap, so the company's prospects are not changed by this note.
Crude oil prices dropped more than 3%, while U.S. businesses stocked up in July.
Good for MEDSThe announced acquisition of Helomics sent the stock sharply higher, reflecting market approval of the deal news.
12 health care companies are changing prices before the market opens on Wednesday.
NeutralMEDS jumped in pre-market trading, but the story contains no company news, so it does not change our reading of MEDS today.
DataMeds AI, Inc. discloses operational results and financial status (MEDS).
NeutralDataMeds AI, Inc. has filed a Form 8-K detailing its results of operations and financial condition, which is crucial for investors to assess the company's current performance and future outlook. This filing could lead to immediate trading activity based on the disclosed information.